GVHD after transfusion of stored RBC concentrates in a solution of mannitol, adenine, phosphate, citrate, glucose, and NaCl following trauma

Transfusion

Volumn 40, Issue 3, 2000, Pages 297-301

  Kita, Toshiyuki ^a   Nei, J ^b   Matsu, T ^b   Yoshiba, H ^b   Matsuda, T ^b   Yahagi, H ^b   Uchida, S ^b   Nakao, S ^b  

^a ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CEFOTIAM; CITRIC ACID; FLUCONAZOLE; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; MANNITOL; METHYLPREDNISOLONE SODIUM SUCCINATE; PHOSPHATE; SODIUM CHLORIDE;

ABDOMINAL BLEEDING; AGED; ARTICLE; BLOOD STORAGE; CASE REPORT; ERYTHROCYTE TRANSFUSION; FEVER; GENE AMPLIFICATION; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE INFECTION; HUMAN; LYMPHOCYTE; MALE; PANCYTOPENIA; RASH; SERRATIA MARCESCENS; SKIN BIOPSY; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADENINE; AGED; BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MANNITOL; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; SODIUM CHLORIDE; WOUNDS AND INJURIES;

EID: 0034067993     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40030297.x     Document Type: Article

References (28)

1. Saito M, Takamatsu H, Nakao S, et al. Transfusion-associated graft-versus-host disease after surgery for bladder cancer. Blood 1993;82:326-7.
2. Högman CF, Åkerblom O, Hedlund K, et al. Red cell suspensions in SAGM medium. Further experience of in vivo survival of red cells, clinical usefulness and plasma-saving effects. Vox Sang 1983;45:217-23.
3. Heaton A, Miripol J, Aster R, et al. 49 to 56 day storage of high hematocrit red cell concentrates using ADSOL™ preservation solution (abstract). Transfusion 1982;22:432.
4. Shiba M, Mura T, Masuyama T, et al. [Preparation and preservation of red cell concentrations in MAP solution by quadruple bag system] (Engl abstract). Jpn J Transfus Med 1991;37:404-10.
5. Wang L, Juji T, Tokunaga K, et al. Brief report: polymorphic microsatellite markers for the diagnosis of graft-versus-host disease. N Engl J Med 1994;330:398-401.
6. Uchida S, Wang L, Yahagi Y, et al. Utility of fingernail DNA for evaluation of chimerism after bone marrow transplantation and for diagnostic testing for transfusion-associated graft-versus-host disease. Blood 1996;87:4015-6.
7. Litt M, Luty JA. Dinucleotide repeat polymorphism at the D6S89 locus. Nucleic Acids Res 1990;18:4301.
8. Polymeropoulos MH, Xiao H, Rath DS, et al. Dinucleotide repeat polymorphism at the int-2 proto-oncogene locus (INT2). Nucleic Acids Res 1991;18:7468.
9. Polymeropoulos MH, Rath DS, Xiao H, et al. A simple sequence repeat polymorphism at the human growth hormone locus. Nucleic Acids Res 1991;19:689.
10. Polymeropoulos MH, Rath DS, Xiao H, et al. Tetranucleotide repeat polymorphism at the human beta-actin related pseudogene H-beta-Ac-psi-2(ACTBP2). Nucleic Acids Res 1992;20:1432.
11. Hata A, Lalouel M. MicroVNTR(CTTT)n at the apo C-III locus. Nucleic Acids Res 1991;19:5098.
12. Kawai S, Maekawajiri S, Tokunaga K, et al. A simple method of HLA-DRB typing using enzymatically amplified DNA and immobilized probes on microtiter plate. Hum Immunol 1994;41:121-6.
13. Bannai M, Tokunaga K, Lin L, et al. Discrimination of human HLA-DRB1 allelesby PCR-SSCP (single-strand conformation polymorphism) method. Eur J Immunogenet 1994;21:1-9.
14. Sasakawa S, Shiba M, Mura T, et al. [Development of additive MAP for storage of red cell concentrates] (Engl abstract). Jpn J Transfus Med 1991;37:398-403.
15. Miyamoto M, Uchida S, Siba M, et al. [Viability and removal of lymphocytes in stored red cell concentrates with MAP solution] (Engl abstract). Jpn J Transfus Med 1991;37:494-500.
16. Sakakibara T, Juji T. Post-transfusion graft-versus-host disease after open heart surgery. Lancet 1986;2:1099.
17. Ito K, Yoshida H, Yanagibashi K, et al. Change of HLA phenotype in postoperative erythroderma. Lancet 1988;1:413-4.
18. Thaler M, Shamiss A, Orgad S, et al. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med 1989;321:25-28.
19. Kruskall MS, Alper CA, Awdeh Z, et al. HLA-homozygous donors and transfusion-associated graft-versus-host disease (letter). N Engl J Med 1990;322:1004-6.
20. Otsuka S, Kunieda K, Kitamura F, et al. The critical role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease in immunocompetent patients. Transfusion 1991;31:260-4.
21. Yasukawa M, Shinozaki F, Hato T, et al. Successful treatment of transfusion-associated graft-versus-host disease. Br J Haematol 1994;86:831-6.
22. Ryo R, Goto M, Takada M, et al. Diagnosis of post-transfusion graft-versus-host disease after formalin-fixation. Int J Hematol 1994;59:297-302.
23. Yankee RA, Grumet FC, Rogentine GN. Platelet transfusion therapy. The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N Engl J Med 1969;281:1208-12.
24. Parkman R, Mosier D, Umansky I, et al. Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. N Engl J Med 1974;290:359-63.
25. Leitman SF. Posttransfusion graft-versus-host disease. In: Smith DM Jr, Silvergleid AJ, eds. Special considerations in transfusing the immunocompromised patient. Arlington: American Association of Blood Banks, 1985:15-37.
26. Tayama T, Naohara T, Haneda K, et al. [X-ray irradiation on blood products for the purpose of prevention of PT-GVHD] (Engl abstract). Jpn J Transfus Med 1990;36:510-6.
27. Harada S, Harada Y, Kajiki A, et al. [The change of immune capacity with aging. 3. On the activating reaction of the peripheral blood lymphocytes with PHA stimulation] (Engl abstract). Iryo 1995;49:40-4.
28. Sakane T, Niwa Y. [Immunological studies of aging. II Age-related changes in natural killer cell activity] (Engl abstract). Jpn J Clin Immunol 1987;10:267-71.